Crohn's Disease — UKMLA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Full blood count (FBC)
Azathioprine can cause bone marrow suppression, leading to leucopenia, thrombocytopenia, or anaemia. Therefore, regular monitoring of the Full Blood Count (FBC) is essential throughout treatment, typically weekly initially then reducing to every 3 months once stable. LFTs should also be monitored as azathioprine can cause hepatotoxicity, but myelosuppression is often considered the most immediate life-threatening risk requiring frequent FBC checks. U&Es, CRP, and folate are monitored for other reasons related to Crohn's disease or general health but are not the primary specific monitoring requirement for azathioprine toxicity related to bone marrow.
Reference: BNF: Azathioprine